Report Details
Global Ultrasound Market Overview
The Global Ultrasound Market was valued at USD 10,724.66 million in 2025 and is projected to reach approximately USD 30,049.26 million by 2040, expanding at a CAGR of 7.11% during the forecast period 2025–2040. Ultrasound has become one of the most widely adopted diagnostic and point-of-care imaging modalities worldwide, valued for being non-invasive, radiation-free, portable, and cost-effective relative to modalities such as MRI and CT.
Growth is driven by the rising global burden of chronic and lifestyle-related diseases, a rapidly ageing population, and demand for early, accurate diagnosis across cardiology, obstetrics & gynecology, radiology, and emergency medicine. The shift toward decentralized, value-based care — supported by handheld and point-of-care ultrasound (POCUS) devices — is broadening reach from hospitals into clinics, ambulatory settings, and home care.
Market Definition
Ultrasound — also called sonography or ultrasonography — is a noninvasive imaging technique that uses high-frequency sound waves to produce real-time pictures or video of organs, tissues, and other soft structures inside the body. A transducer (probe) sends sound waves into the body and captures the echoes that bounce back off internal structures; a computer then converts these signals into images displayed on a screen. The resulting image is called a sonogram. Because it does not use ionizing radiation, ultrasound is regarded as a safe, low-power imaging method with no known harmful effects when performed by trained professionals.
In clinical practice, ultrasound spans three broad categories — pregnancy (prenatal) imaging, diagnostic imaging of internal organs and tissues, and image guidance for procedures such as biopsies and needle placement. It supports the assessment of blood flow, gallbladder and liver conditions, thyroid and breast evaluation, musculoskeletal and vascular disorders, and fetal monitoring, making it one of the most versatile and widely deployed modalities across modern healthcare settings. For the purpose of this report, the Global Ultrasound Market encompasses ultrasound systems, devices, transducers, and associated software used across diagnostic, point-of-care, and therapeutic applications worldwide.
Reference sources: Cleveland Clinic | National Cancer Institute (NCI) | MedlinePlus | Mayo Clinic
Market Size & Growth Outlook (USD Million)
Market Growth Drivers
- Rising prevalence of chronic diseases (cardiovascular, oncological, gynecological) fueling demand for early diagnostic imaging.
- Rapid adoption of point-of-care and handheld ultrasound (POCUS) enabling bedside and remote diagnostics.
- Integration of artificial intelligence (AI) improving image quality, diagnostic accuracy, and clinical throughput.
- Growing preference for radiation-free, non-invasive imaging over CT and X-ray.
- Expanding healthcare infrastructure across Asia-Pacific, Latin America, and the Middle East & Africa.
Market Restraints & Challenges
- High capital cost of premium cart-based systems limiting adoption in low-resource settings.
- Shortage of trained sonographers affecting diagnostic consistency.
- Stringent regulatory approval pathways and reimbursement variability across regions.
Market Segmentation – By Technology
The market is segmented by technology, reflecting the evolution from conventional 2D imaging toward advanced multi-dimensional and Doppler-based systems. Continuous innovation in transducer design, beamforming, and AI-assisted processing is enabling higher-resolution, real-time visualization.
| Technology Segment | Description |
|---|---|
| 2D Ultrasound | Standard cross-sectional grayscale imaging; the most widely used, cost-effective modality across general diagnostics. |
| 3D & 4D Ultrasound | Volumetric and real-time motion imaging, used in obstetrics, cardiology, and image-guided procedures. |
| Doppler Ultrasound | Blood-flow and hemodynamic assessment, critical in vascular and cardiac diagnostics. |
| High-Intensity Focused Ultrasound (HIFU) | Therapeutic ultrasound for non-invasive tissue ablation and targeted treatment. |
| AI-Enabled & Handheld / POCUS | Portable, connected, AI-augmented systems driving decentralized point-of-care diagnostics. |
Key Players in the Global Ultrasound Market
The competitive landscape is dominated by established global medical technology leaders with strong innovation pipelines and growing investment in AI-driven ultrasound. The report profiles the following key players operating in the Global Ultrasound Market:
- Koninklijke Philips NV
- Mindray Medical International Ltd.
- GE Healthcare
- FUJIFILM Holdings Corp.
- Esaote SpA
- Hitachi Ltd.
- Hologic, Inc.
- Siemens AG
- Canon Medical Systems Corp.
- Samsung Medison Co., Ltd.
- Abbott Laboratories
- Canon, Inc.
- Analogic Corp.
- Samsung Electronics Co., Ltd.
- Siemens Healthcare Kft.
- ALPINION Medical Systems Co., Ltd.
- Shimadzu Corp.
- Johnson & Johnson
- Sonablate Corp.
- Terumo Corp.
- Hitachi Medical Corp.
- Insightec Ltd.
- Carestream Health SA
- EDAP TMS SA
- TOSHIBA Corp.
- Fukuda Denshi Co., Ltd.
- Cook Medical LLC
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Shanghai Electric Group Co., Ltd.
- Théraclion SA
- Image Guided Therapy
- Cardinal Health, Inc.
- FUJIFILM SonoSite, Inc.
- Teleflex, Inc.
- BIOTRONIK SE & Co. KG
- Cardiovascular Systems, Inc.
- Eye Tech Care SA
- Verasonics, Inc.
- AngioDynamics, Inc.
- Biosensors International Group Ltd.
- ContextVision AB
- Chison Medical Technologies Co., Ltd.
- Everlight Radiology Ltd.
- RamSoft, Inc.
- Siemens Healthcare GmbH
- Accutome, Inc.
- Hitachi Medical Systems SAS
- Carl Zeiss Meditec AG
- Opsens, Inc.
- ACIST Medical Systems, Inc.
- Toshiba Medical Systems
- Infraredx, Inc.
- Straub Medical AG
- Sonoscanner SARL
- Eli Lilly & Co.
- Asahi Kasei Corp.
- Edwards Lifesciences Corp.
- W. L. Gore & Associates, Inc.
- Bracco SpA
- Medtronic, Inc.
- Philips Image Guided Therapy Corp.
- Optos Plc
- Neusoft Medical Systems Co., Ltd.
- Stentys SA
- Dilon Technologies LLC
- Meda Co., Ltd.
- Spacelabs Healthcare, Inc.
- Lantheus Medical Imaging, Inc.
- Terason (Pty) Ltd.
- Chongqing Haifu (HIFU) Technology Co., Ltd.
- Mirabilis Medica, Inc.
- Telemed SpA
- International Business Machines Corp.
- Pfizer Inc.
- Merck & Co., Inc.
- GSK Plc
- Becton, Dickinson & Co.
- Stryker Corp.
- Thermo Fisher Scientific, Inc.
- Roche Holding AG
- Daiichi Sankyo Co., Ltd.
- Bruker Corp.
- CONMED Corp.
- Elekta AB
- Lepu Medical Technology (Beijing) Co., Ltd.
- Allergan Ltd. (Ireland)
- MicroPort Scientific Corp.
- Asahi Intecc Co., Ltd.
- bioMérieux SA
- Covidien Unlimited Co.
- Fuji Pharma Co., Ltd.
- BenQ Medical Technology Corp.
- Medistim ASA
- Merge Healthcare, Inc.
- Bayer HealthCare AG
- Contec Medical Systems Co. Ltd.
- Carl Zeiss AG
- Avinger, Inc.
- St. Jude Medical LLC
- Argon Medical Devices, Inc.
- Others
Key Player Revenue Comparison (USD Million, Latest Reported Year)
Philips 2025; Mindray 2025; GE HealthCare 2024; FUJIFILM 2024 (group-level revenue)
Company Analysis
1. Koninklijke Philips N.V. (Royal Philips)
| Website | www.philips.com |
| Founded | 1891 |
| Headquarters | Amsterdam, Netherlands |
| Type | Public Company |
Company Overview: Koninklijke Philips N.V. (Royal Philips) is a Netherlands-based global health technology company focused on improving people's health and well-being through meaningful innovation. Evolving from an electrical and lighting business into a focused health technology organization, Philips delivers technologies, products, software, and services across diagnostic imaging, ultrasound, image-guided therapy, patient monitoring, enterprise informatics, and personal health across hospital and home-care settings.
Product Summary: A comprehensive ultrasound portfolio spanning premium cart-based systems, general imaging, and point-of-care solutions including the Lumify handheld platform. [Systems] [POCUS] [Lumify]
Recent Developments: Launched the Alturion ultrasound system with AI-powered workflows, received FDA 510(k) clearance for Elevate Plus on EPIQ Elite and Affiniti, introduced new 2D/3D cardiovascular ultrasound systems, and committed a USD 150 million manufacturing investment to expand AI ultrasound capabilities. [Alturion] [FDA Clearance]
Revenue (USD M): 2025 – 19,260.72 | 2024 – 19,462.68 | 2023 – 19,622.52 [Annual Report]
2. Mindray Bio-Medical Electronics Co., Ltd.
| Website | www.mindray.com |
| Founded | 1991 |
| Headquarters | Shenzhen, China |
| Type | Public Company |
Company Overview: Mindray Bio-Medical Electronics Co., Ltd. is a leading global provider of medical devices and healthcare solutions, designing and manufacturing patient monitoring systems, in-vitro diagnostic equipment, and medical imaging solutions. Its business spans three segments — Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging Systems — with a focus on innovation, accessibility, and cost-effective technology delivered across 190+ countries.
Product Summary: A broad ultrasound range covering primary care, portable, point-of-care, and general imaging systems including the DC-30 and DC-40 platforms. [Portfolio] [POCUS]
Recent Developments: Expanded the Hepatus series for gastroenterology imaging, unveiled the ultra-premium Resona A20 at RSNA 2025, introduced a breakthrough 2-in-1 handheld ultrasound with multi-device connectivity, and launched a wireless handheld ultrasound for whole-body scanning. [Resona A20] [Handheld]
Revenue (USD M): 2025 – 4,659.48 | 2024 – 5,141.64 | 2023 – 4,890.48 [Financials]
3. GE HealthCare
| Website | www.gehealthcare.com |
| Founded | 1994 |
| Headquarters | Chicago, United States |
| Type | Public Company |
Company Overview: GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions provider focused on improving patient outcomes through advanced imaging systems, ultrasound, patient monitoring, and healthcare IT. Its portfolio spans MRI, CT, X-ray, molecular imaging, contrast media, and radiopharmaceuticals, with emphasis on precision care, digital transformation, and AI-driven healthcare serving hospitals, clinics, and research institutions worldwide.
Product Summary: A full ultrasound spectrum including the LOGIQ, Vivid, and Venue families spanning radiology, cardiology, and point-of-care applications. [Portfolio] [Vivid]
Recent Developments: Introduced next-level LOGIQ ultrasound systems, debuted AI-enabled Venue family systems, launched an AI-enabled ultrasound series for women's health, completed a USD 53 million acquisition of an AI ultrasound business, and secured a USD 44 million BARDA contract for AI ultrasound. [LOGIQ] [AI Acquisition]
Revenue (USD M): 2024 – 19,672 | 2023 – 19,552 | 2022 – 18,341 [Annual Report]
4. FUJIFILM Holdings Corporation
| Website | www.fujifilm.com |
| Founded | 1934 |
| Headquarters | Tokyo, Japan |
| Type | Publicly Listed Holding Company |
Company Overview: FUJIFILM Holdings Corporation is a Japan-based global holding company managing the Fujifilm Group across Healthcare, Electronics, Business Innovation, and Imaging businesses. Originally established in 1934 as Fuji Photo Film Co., Ltd. and reorganized into a holding company in 2006, its Healthcare business covers medical systems, Bio-CDMO, and life-science solutions, supported by a broad global network of consolidated subsidiaries.
Product Summary: A diverse ultrasound and endoscopic ultrasound portfolio, including gynecology-focused Innomuse solutions and Sonosite point-of-care systems. [Products] [Innomuse]
Recent Developments: Launched its most advanced endoscopic ultrasound in India, expanded Sonosite with the iLook ultrasound solution for vascular access, renewed its ultrasound diagnostic business collaboration with PENTAX Medical, and finalized the acquisition of Hitachi's imaging business. [Endoscopic] [Hitachi]
Revenue (USD M): 2024 – 21,109.57 | 2023 – 21,065.96 | 2022 – 21,743.99 [Integrated Report]
Unlock the Full Global Ultrasound Market Report
Complete segmentation, regional analysis, competitive benchmarking, and 2025–2040 forecasts. Contact sales@globaldatarouteanalytics.com
1. Introduction
1.1. Market Definition
1.2. Study Scope & Segmentation
1.3. Research Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Snapshot (2025–2040)
2.2. Key Findings
2.3. Analyst Recommendations
3. Market Overview
3.1. Market Size & Growth Outlook (USD Million)
3.2. Market Growth Drivers
3.3. Market Restraints & Challenges
3.4. Market Opportunities
3.5. Value Chain Analysis
3.6. Porter’s Five Forces Analysis
4. Market Segmentation – By Technology
4.1. 2D Ultrasound
4.2. 3D & 4D Ultrasound
4.3. Doppler Ultrasound
4.4. High-Intensity Focused Ultrasound (HIFU)
4.5. AI-Enabled & Handheld / Point-of-Care Ultrasound (POCUS)
5. Market Segmentation – By Application
5.1. Radiology / General Imaging
5.2. Cardiology
5.3. Obstetrics & Gynecology
5.4. Vascular
5.5. Musculoskeletal
5.6. Others
6. Market Segmentation – By End User
6.1. Hospitals
6.2. Diagnostic Imaging Centers
6.3. Ambulatory Care & Clinics
6.4. Others
7. Regional Analysis
7.1. North America
7.2. Europe
7.3. Asia-Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Competitive Landscape
8.1. Market Share Analysis
8.2. Key Player Revenue Comparison
8.3. Recent Developments & Strategic Initiatives
9. Company Profiles (Key Players)
9.1. Koninklijke Philips NV
9.2. Mindray Medical International Ltd.
9.3. GE Healthcare
9.4. FUJIFILM Holdings Corp.
9.5. Esaote SpA
9.6. Hitachi Ltd.
9.7. Hologic, Inc.
9.8. Siemens AG
9.9. Canon Medical Systems Corp.
9.10. Samsung Medison Co., Ltd.
9.11. Abbott Laboratories
9.12. Canon, Inc.
9.13. Analogic Corp.
9.14. Samsung Electronics Co., Ltd.
9.15. Siemens Healthcare Kft.
9.16. ALPINION Medical Systems Co., Ltd.
9.17. Shimadzu Corp.
9.18. Johnson & Johnson
9.19. Sonablate Corp.
9.20. Terumo Corp.
9.21. Hitachi Medical Corp.
9.22. Insightec Ltd.
9.23. Carestream Health SA
9.24. EDAP TMS SA
9.25. TOSHIBA Corp.
9.26. Fukuda Denshi Co., Ltd.
9.27. Cook Medical LLC
9.28. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.29. Shanghai Electric Group Co., Ltd.
9.30. Théraclion SA
9.31. Image Guided Therapy
9.32. Cardinal Health, Inc.
9.33. FUJIFILM SonoSite, Inc.
9.34. Teleflex, Inc.
9.35. BIOTRONIK SE & Co. KG
9.36. Cardiovascular Systems, Inc.
9.37. Eye Tech Care SA
9.38. Verasonics, Inc.
9.39. AngioDynamics, Inc.
9.40. Biosensors International Group Ltd.
9.41. ContextVision AB
9.42. Chison Medical Technologies Co., Ltd.
9.43. Everlight Radiology Ltd.
9.44. RamSoft, Inc.
9.45. Siemens Healthcare GmbH
9.46. Accutome, Inc.
9.47. Hitachi Medical Systems SAS
9.48. Carl Zeiss Meditec AG
9.49. Opsens, Inc.
9.50. ACIST Medical Systems, Inc.
9.51. Toshiba Medical Systems
9.52. Infraredx, Inc.
9.53. Straub Medical AG
9.54. Sonoscanner SARL
9.55. Eli Lilly & Co.
9.56. Asahi Kasei Corp.
9.57. Edwards Lifesciences Corp.
9.58. W. L. Gore & Associates, Inc.
9.59. Bracco SpA
9.60. Medtronic, Inc.
9.61. Philips Image Guided Therapy Corp.
9.62. Optos Plc
9.63. Neusoft Medical Systems Co., Ltd.
9.64. Stentys SA
9.65. Dilon Technologies LLC
9.66. Meda Co., Ltd.
9.67. Spacelabs Healthcare, Inc.
9.68. Lantheus Medical Imaging, Inc.
9.69. Terason (Pty) Ltd.
9.70. Chongqing Haifu (HIFU) Technology Co., Ltd.
9.71. Mirabilis Medica, Inc.
9.72. Telemed SpA
9.73. International Business Machines Corp.
9.74. Pfizer Inc.
9.75. Merck & Co., Inc.
9.76. GSK Plc
9.77. Becton, Dickinson & Co.
9.78. Stryker Corp.
9.79. Thermo Fisher Scientific, Inc.
9.80. Roche Holding AG
9.81. Daiichi Sankyo Co., Ltd.
9.82. Bruker Corp.
9.83. CONMED Corp.
9.84. Elekta AB
9.85. Lepu Medical Technology (Beijing) Co., Ltd.
9.86. Allergan Ltd. (Ireland)
9.87. MicroPort Scientific Corp.
9.88. Asahi Intecc Co., Ltd.
9.89. bioMérieux SA
9.90. Covidien Unlimited Co.
9.91. Fuji Pharma Co., Ltd.
9.92. BenQ Medical Technology Corp.
9.93. Medistim ASA
9.94. Merge Healthcare, Inc.
9.95. Bayer HealthCare AG
9.96. Contec Medical Systems Co. Ltd.
9.97. Carl Zeiss AG
9.98. Avinger, Inc.
9.99. St. Jude Medical LLC
9.100. Argon Medical Devices, Inc.
9.101. Others
10. Conclusion & Analyst Outlook
Key Players
- Koninklijke Philips NV
- Mindray Medical International Ltd.
- GE Healthcare
- FUJIFILM Holdings Corp.
- Esaote SpA
- Hitachi Ltd.
- Hologic, Inc.
- Siemens AG
- Canon Medical Systems Corp.
- Samsung Medison Co., Ltd.
- Abbott Laboratories
- Canon, Inc.
- Analogic Corp.
- Samsung Electronics Co., Ltd.
- Siemens Healthcare Kft.
- ALPINION Medical Systems Co., Ltd.
- Shimadzu Corp.
- Johnson & Johnson
- Sonablate Corp.
- Terumo Corp.
- Hitachi Medical Corp.
- Insightec Ltd.
- Carestream Health SA
- EDAP TMS SA
- TOSHIBA Corp.
- Fukuda Denshi Co., Ltd.
- Cook Medical LLC
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Shanghai Electric Group Co., Ltd.
- Théraclion SA
- Image Guided Therapy
- Cardinal Health, Inc.
- FUJIFILM SonoSite, Inc.
- Teleflex, Inc.
- BIOTRONIK SE & Co. KG
- Cardiovascular Systems, Inc.
- Eye Tech Care SA
- Verasonics, Inc.
- AngioDynamics, Inc.
- Biosensors International Group Ltd.
- ContextVision AB
- Chison Medical Technologies Co., Ltd.
- Everlight Radiology Ltd.
- RamSoft, Inc.
- Siemens Healthcare GmbH
- Accutome, Inc.
- Hitachi Medical Systems SAS
- Carl Zeiss Meditec AG
- Opsens, Inc.
- ACIST Medical Systems, Inc.
- Toshiba Medical Systems
- Infraredx, Inc.
- Straub Medical AG
- Sonoscanner SARL
- Eli Lilly & Co.
- Asahi Kasei Corp.
- Edwards Lifesciences Corp.
- W. L. Gore & Associates, Inc.
- Bracco SpA
- Medtronic, Inc.
- Philips Image Guided Therapy Corp.
- Optos Plc
- Neusoft Medical Systems Co., Ltd.
- Stentys SA
- Dilon Technologies LLC
- Meda Co., Ltd.
- Spacelabs Healthcare, Inc.
- Lantheus Medical Imaging, Inc.
- Terason (Pty) Ltd.
- Chongqing Haifu (HIFU) Technology Co., Ltd.
- Mirabilis Medica, Inc.
- Telemed SpA
- International Business Machines Corp.
- Pfizer Inc.
- Merck & Co., Inc.
- GSK Plc
- Becton, Dickinson & Co.
- Stryker Corp.
- Thermo Fisher Scientific, Inc.
- Roche Holding AG
- Daiichi Sankyo Co., Ltd.
- Bruker Corp.
- CONMED Corp.
- Elekta AB
- Lepu Medical Technology (Beijing) Co., Ltd.
- Allergan Ltd. (Ireland)
- MicroPort Scientific Corp.
- Asahi Intecc Co., Ltd.
- bioMérieux SA
- Covidien Unlimited Co.
- Fuji Pharma Co., Ltd.
- BenQ Medical Technology Corp.
- Medistim ASA
- Merge Healthcare, Inc.
- Bayer HealthCare AG
- Contec Medical Systems Co. Ltd.
- Carl Zeiss AG
- Avinger, Inc.
- St. Jude Medical LLC
- Argon Medical Devices, Inc.
- Others
Market Segmentation
By Technology
- 2D Ultrasound
- 3D & 4D Ultrasound
- Doppler Ultrasound
- High-Intensity Focused Ultrasound (HIFU)
- AI-Enabled & Handheld / Point-of-Care Ultrasound (POCUS)
By Application
- Radiology / General Imaging
- Cardiology
- Obstetrics & Gynecology
- Vascular
- Musculoskeletal
- Others
By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Care & Clinics
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Download Sample Request Form
Make an Inquiry
Ask for Discount
Frequently Asked Questions
What is the size of the Global Ultrasound Market?
The Global Ultrasound Market was valued at USD 10,724.66 million in 2025 and is projected to reach approximately USD 30,049.26 million by 2040.
What is the CAGR of the Global Ultrasound Market?
The market is expected to expand at a CAGR of 7.11% during the forecast period 2025–2040.
Who are the key players in the Global Ultrasound Market?
Leading players include Koninklijke Philips N.V. (Royal Philips), Mindray Bio-Medical Electronics Co., Ltd., GE HealthCare, and FUJIFILM Holdings Corporation.
How is the Global Ultrasound Market segmented?
The market is segmented by technology (2D, 3D & 4D, Doppler, HIFU, AI-enabled/handheld POCUS), by application, by end user, and by region.
Which factors are driving growth in the Global Ultrasound Market?
Growth is driven by the rising burden of chronic diseases, an ageing population, rapid adoption of point-of-care and handheld ultrasound, and integration of AI into ultrasound imaging.